The Valley Desk

ArticleJournal of cancer research and clinical oncologyPublished

Outcomes of hepatocellular carcinoma by etiology with first-line atezolizumab and bevacizumab: a real-world analysis

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Philadelphia VA Medical Center, University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Journal of cancer research and clinical oncology
Published
Subject terms
Humans; Carcinoma, Hepatocellular; Liver Neoplasms; Ethanol; Antibodies, Monoclonal, Humanized; Non-alcoholic Fatty Liver Disease; Bevacizumab; Hepatocellular carcinoma; Immunotherapy; Outcomes; NASH
PubMed ID
36862158
PubMed Central ID
PMC11044531
Added to directory
Source checked

Report a correction or request removal